Viking Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $99.41 on 02/28/24 and a low of $8.28 for the same time frame on 10/26/23.
52-week price history of VKTX Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Viking Therapeutics Inc’s current trading price is -43.47% away from its 52-week high, while its distance from the 52-week low is 578.74%. The stock’s price range during this period has spanned from $8.28 to $99.41. In the Healthcare sector, the Viking Therapeutics Inc’s shares surpassed a trading volume of approximately 1.83 million for the day, which was noticeably lower compared to the average daily volume of 9.3.9 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Viking Therapeutics Inc (VKTX) has experienced a quarterly decline of -22.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.23B and boasts a workforce of 27 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 62.90, with a change in price of -14.84. Similarly, Viking Therapeutics Inc recorded 3,712,601 in trading volume during the last 100 days, posting a change of -20.89%.
Examining VKTX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for VKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
VKTX Stock Stochastic Average
Today’s raw stochastic average for Viking Therapeutics Inc over the last 50 days is 40.60%.This indicates a increase from the raw stochastic average of the past 20 days, which was 37.59%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 42.03% and 38.09%, respectively.
VKTX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 201.99%.However, over the last six months, we can see a weaker performance of 77.15%. Over the last 30 days, the price of VKTX has leaped by -5.36%. And in the last five days, it has surged by 5.38%.
